enzh-TWfrdeitjaptrues
You are here: Home Publications Pub-2015 Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemia

Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemia

Legal | Privacy

Copyright © Bing Center for Waldenstrom's Macroglobulinemia 2000 - 2021